- Home
- PTGX vs ASB Comparison
PTGX vs ASB Comparison
Compare PTGX & ASB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PTGX | ASB |
|---|---|---|
| Founded | 2006 | 1861 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 4.5B |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | PTGX | ASB |
|---|---|---|
| Price | $88.83 | $26.58 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 12 |
| Target Price | ★ $90.56 | $28.00 |
| AVG Volume (30 Days) | 1.0M | ★ 2.1M |
| Earning Date | 11-06-2025 | 01-22-2026 |
| Dividend Yield | N/A | ★ 3.62% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.72 | ★ 0.98 |
| Revenue | $209,217,000.00 | ★ $1,097,713,000.00 |
| Revenue This Year | N/A | $57.84 |
| Revenue Next Year | $288.98 | $9.24 |
| P/E Ratio | $123.35 | ★ $27.06 |
| Revenue Growth | N/A | ★ 8.93 |
| 52 Week Low | $33.70 | $18.32 |
| 52 Week High | $96.54 | $27.58 |
Technical Indicators
Market Signals| Indicator | PTGX | ASB |
|---|---|---|
| Relative Strength Index (RSI) | 53.99 | 54.95 |
| Support Level | $84.11 | $26.28 |
| Resistance Level | $90.00 | $26.97 |
| Average True Range (ATR) | 3.31 | 0.50 |
| MACD | -0.75 | -0.04 |
| Stochastic Oscillator | 38.05 | 41.14 |
Price Performance
Historical ComparisonAbout PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About ASB Associated Banc-Corp
Associated Banc-Corp is a bank holding company. The company through its subsidiaries provides a broad array of banking and nonbanking products and services to individuals and businesses. The company operates in three reportable segments; Corporate and Commercial Specialty; Community, Consumer, and Business; and Risk Management and Shared Services. The majority of its revenue is derived from the Corporate and Commercial Specialty and Community, Consumer, and Business segments.